That's interesting. I didn't realize he had been an advisor.
The focus on delivery is probably because that's the upgrade, the valve itself is still the Evolut Pro, which Medtronic does promote as having excellent hemodynamics in their marketing materials, which every company does whether the hemodynamics are relatively excellent or not, so I don't think them not mentioning hemodynamics in the CE Mark press release means anything.
AVR late breaking trial presentation at London Valves, page-18
Add to My Watchlist
What is My Watchlist?
